Here are relevant reports on : automotive-diagnostic-market
-
Surface Disinfectant Market by Composition (Alcohols, Chlorine, Quaternary Ammonium, H2O2), Type (Liquid, Wipes, Sprays), Application (Surface Disinfection), End User (Hospitals, Clinics, Diagnostic Laboratories), & Region - Global Forecast to 2030
The global surface disinfectant market, valued at US$2.84B in 2024, is forecasted to grow at a 7.6% CAGR, reaching US$3.04B by 2025 and US$4.38B by 2030. Market growth in the Asia Pacific can be attributed to the rising prevalence of hospital-acquired infections and expanding healthcare facilities. Additionally, an increased presence of pharmaceutical and biotechnology companies also contributes to market growth.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
AI Agents in Healthcare Market by Function (Scheduling, Billing, Diagnostic, Treatment, RPM, Telehealth), Offering (Multi-Agent), Architecture (Contextual, Conversational), End User (Hospital, ACS, Imaging Center), Trends, Growth - Global Forecast to 2030
The global AI Agents in Healthcare market, valued at US$0.76 billion in 2024, stood at US$1.11 billion in 2025 and is projected to advance at a resilient CAGR of 44.1% from 2025 to 2030, culminating in a forecasted valuation of US$6.92 billion by the end of the period. Advances in generative AI, natural language processing, and seamless integration with electronic health records (EHRs) are enabling AI agents to handle a range of tasks, from patient engagement and appointment scheduling to clinical decision support and documentation assistance.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecasts to 2023
The global creatinine measurement market is projected to reach USD 564.5 Million by 2023, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. The creatinine measurement market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include F. Hoffmann-la Roche Ltd (Switzerland)., Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific Inc (US), Siemens Healthineers (Germany), Randox Laboratories (UK)., Pointe Scientific, Inc (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories, Inc (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecasts to 2023
The global colposcopy market is projected to reach USD 740.1 Million by 2023, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Minimal Residual Disease Market by Product (Kits, Instruments), Technology (PCR, NGS), Application (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors), End User (Hospitals, Diagnostic Labs, Research Institutes), & Region - Global Forecast to 2029
The global minimal residual disease testing market, valued at US$1.27 billion in 2023, stood at US$1.43 billion in 2024 and is projected to advance at a resilient CAGR of 12.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.55 billion by the end of the period. The market is driven by the growing prevalence of cancer globally and increasing funding from international organizations and governments for cancer prevention programs.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
High-Resolution Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast to 2021
The global high-resolution melting analysis market is projected to grow at a CAGR of 3.1%. Rising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Rolling Stock Management Market by Management (Rail, Infrastructure), Rail (Remote Diagnostic, Wayside, Train, Asset, Cab Advisory), Infrastructure (Control Room, Station, Automatic Fare Collection), Maintenance Service & Region - Global Forecast to 2025
The global rolling stock management market is projected to grow from USD 42.8 billion in 2019 to reach USD 58.4 billion by 2025, at a CAGR of 5.32%. The rising concerns over safety, security, inspection, maintenance, and in the transport business has led to the growth of the rolling stock management market. It not only includes the fact of reducing long term cost but also mitigating the traditional methods of maintenance. Transport can be through the medium of air, road, or train but its efficiency and effect on the environment. The emerging nations support railways as a well-suited means of mass transport for passengers and freight.Bombardier (Canada), Alstom (France), General Electric (US), and Siemens (Germany).
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording, ICE, X-ray Systems), Ablation Catheters (Cryoablation, Radiofrequency, Laser, Microwave), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), End Use-Global Forecast to 2030
The global electrophysiology market, valued at US$11.41 billion in 2024, stood at US$12.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$21.72 billion by the end of the period. The rise of the electrophysiology market can be attributed to several drivers: the increasing prevalence of cardiovascular diseases, including arrhythmias and atrial fibrillation; patients and healthcare providers are increasingly favoring minimally invasive procedures over traditional surgical interventions; electrophysiological techniques, such as catheter ablation, offer less invasive options for treating certain cardiac arrhythmias; and government support and initiatives aimed at improving healthcare infrastructure and funding research and development in electrophysiology also contribute to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers) & Region - Global Forecast to 2026
The global hospital acquired infection control market growth is primed to transition from $29.1 billion in 2021 to $31.3 billion by 2026, showcasing a strong CAGR of 1.5%. The growth of this market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19.
- Published: August 2021
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
